当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:113.82亿  总市值:113.82亿
流通股本:4.16亿   总股本:4.16亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金657,961,769.62306,402,043.441,720,563,262.481,213,054,527.77
  收到的税费返还780,714.19780,714.19722,037.1722,037.1
  收到其他与经营活动有关的现金24,556,465.5312,681,226.6356,365,430.9642,165,914.41
  经营活动现金流入小计683,298,949.34319,863,984.261,777,650,730.541,255,942,479.28
  购买商品、接受劳务支付的现金121,092,610.3545,091,863.47299,316,629.39232,953,361.46
  支付给职工以及为职工支付的现金208,200,900.16137,474,832.93345,973,182.35276,959,344.71
  支付的各项税费43,715,463.3914,658,153.37178,169,372.99135,750,830.49
  支付其他与经营活动有关的现金183,809,029.8584,143,585.54453,232,119.45319,100,880.76
  经营活动现金流出小计556,818,003.75281,368,435.311,276,691,304.18964,764,417.42
  经营活动产生的现金流量净额126,480,945.5938,495,548.95500,959,426.36291,178,061.86
二、投资活动产生的现金流量:
  收回投资收到的现金2,329,320,000759,000,0004,889,178,236.93,174,245,266.25
  取得投资收益收到的现金14,136,8114,645,263.127,197,078.3620,855,345.46
  处置固定资产、无形资产和其他长期资产收回的现金净额--10,982,149.8210,887,081.56
  收到的其他与投资活动有关的现金--5,000,000-
  投资活动现金流入小计2,343,456,811763,645,263.14,932,357,465.083,205,987,693.27
  购建固定资产、无形资产和其他长期资产支付的现金182,317,662.1478,107,021.81362,483,478.94260,020,189.93
  投资支付的现金2,799,000,0001,259,000,0004,732,370,6203,138,370,620
  支付其他与投资活动有关的现金264,510.84250,016.78333,061.3844,707.12
  投资活动现金流出小计2,981,582,172.981,337,357,038.595,095,187,160.323,398,435,517.05
  投资活动产生的现金流量净额-638,125,361.98-573,711,775.49-162,829,695.24-192,447,823.78
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金329,224,279.84-329,381,580.8329,362,680.8
  支付其他与筹资活动有关的现金3,034,254.62611,036.0555,850,433.0153,427,214.44
  筹资活动现金流出小计332,258,534.46611,036.05385,232,013.81382,789,895.24
  筹资活动产生的现金流量净额-332,258,534.46-611,036.05-385,232,013.81-382,789,895.24
四、汇率变动对现金及现金等价物的影响980,417.67460,866.88548,387.95370,851.59
五、现金及现金等价物净增加额-842,922,533.18-535,366,395.71-46,553,894.74-283,688,805.57
  加:期初现金及现金等价物余额4,498,051,446.794,498,051,446.794,544,605,341.534,544,605,341.53
  期末现金及现金等价物余额3,655,128,913.613,962,685,051.084,498,051,446.794,260,916,535.96
补充资料:
  净利润122,294,675.25-342,821,554.27-
  资产减值准备16,369,205.15-75,387,882.53-
  固定资产和投资性房地产折旧79,264,838.3-160,808,964.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧79,264,838.3-160,808,964.68-
  无形资产摊销3,572,592.27-6,701,294.62-
  长期待摊费用摊销2,069,128.26-3,810,695.97-
  处置固定资产、无形资产和其他长期资产的损失---88,290.32-
  固定资产报废损失278,061.06-1,803,639.74-
  公允价值变动损失2,669,752.62-33,421,748.59-
  财务费用-650,644.23-286,024.6-
  投资损失-13,267,031.43--15,549,868.15-
  递延所得税-11,743,323.95--2,627,466.06-
  其中:递延所得税资产减少-11,639,468.05-6,674,461.58-
    递延所得税负债增加-103,855.9--9,301,927.64-
  存货的减少-16,577,383.02--73,274,232.69-
  经营性应收项目的减少-71,066,385.17--18,023,812.39-
  经营性应付项目的增加-5,495,052.05--27,587,415.83-
  其他32,466.84-55,417.38-
  现金的期末余额3,655,128,913.61-4,498,051,446.79-
  减:现金的期初余额4,498,051,446.79-4,544,605,341.53-
  现金及现金等价物的净增加额-842,922,533.18--46,553,894.74-
公告日期2025-08-292025-04-302025-04-242024-10-30
审计意见(境内)标准无保留意见
TOP↑